# Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

> **NCT01095250** · PHASE3 · TERMINATED · sponsor: **Novartis Pharmaceuticals** · enrollment: 30 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** AIN457
- **DRUG:** AIN457
- **DRUG:** AIN457
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01095250
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Terminated: Study in Behcet's disease with mostly active uveitis did not meet its primary endpoint.
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01095250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01095250, "Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01095250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*